2008 annual financial data
Fennec Pharmaceuticals 2008 Operating income growth
Direct answer
Operating income growth was 2.14%.
Operating income was -13,886,000 USD and net income was -13,600,000 USD.
Operating cash flow was -10,808,000 USD.
Get free Fennec Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- Not available
- Operating income
- -13,886,000 USD
- Net income
- -13,600,000 USD
- Operating cash flow
- -10,808,000 USD